机器学习定义诊断标准:区分垂体转移与免疫检查点抑制剂相关自身免疫性垂体炎
该研究通过系统检索MEDLINE和EMBASE数据库(截至2018年10月),纳入65项研究共122例患者(垂体炎60例,垂体转移62例),利用机器学习(随机森林算法)基于6个影像学和3个临床特征构建并验证了区分垂体转移与免疫检查点抑制剂诱导的自身免疫性垂体炎的多变量预测模型。模型在训练集AUC为0.91(0.82, 1.00),P<10^-8;验证集AUC为0.94(0.80, 1.00),P=0.001。该影像学特征可用于辅助临床决策。
要点
- 新发垂体病变在免疫检查点抑制剂治疗患者中可达18%,需鉴别垂体转移与自身免疫性垂体炎。
- 机器学习模型基于6个影像和3个临床特征,训练集AUC 0.91,验证集AUC 0.94。
- 模型预测垂体转移的病变特征:≥2 cm,或<2 cm伴不均匀强化和海绵窦延伸。
核心结论
- 基于影像的机器学习特征可区分垂体转移与免疫检查点抑制剂诱导的自身免疫性垂体炎,辅助临床决策。
研究设计与样本
- 系统检索MEDLINE和EMBASE数据库至2018年10月,纳入65项研究共122例患者(垂体炎60例,垂体转移62例)。
- 采用随机森林算法,基于6个影像学和3个临床特征构建多变量预测模型,并在训练集和验证集中评估。
主要发现
- 训练集AUC=0.91(0.82, 1.00),P<10^-8;验证集AUC=0.94(0.80, 1.00),P=0.001。
- 模型预测垂体转移的病变特征为:≥2 cm,或<2 cm但伴不均匀对比增强和海绵窦延伸。
关键数值与推荐
- 垂体转移预测标准:病变≥2 cm,或<2 cm伴不均匀强化和海绵窦延伸。
- 训练集AUC 0.91(0.82, 1.00),P<10^-8;验证集AUC 0.94(0.80, 1.00),P=0.001。
临床怎么用
- 对于免疫检查点抑制剂治疗中出现新发垂体病变的癌症患者,可使用该影像学特征辅助鉴别垂体转移与自身免疫性垂体炎。
局限性
- 完整影像学数据仅82例患者可用(训练集62例,验证集20例),样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: New-onset pituitary gland lesions are observed in up to 18% of cancer patients undergoing treatment with immune checkpoint blockers (ICB). We aimed to develop and validate an imaging-based decision-making algorithm for use by the clinician that helps differentiate pituitary metastasis (PM) from ICB-induced autoimmune hypophysitis (HP). MATERIALS AND METHODS: A systematic search was performed in the MEDLINE and EMBASE databases up to October 2018 to identify studies concerning PM and HP in patients treated with cytotoxic T-lymphocyte-associated protein 4 and programmed cell death (ligand) 1. The reference standard for diagnosis was confirmation by histology or response on follow-up imaging. Patients from included studies were randomly assigned to the training set or the validation set. Using machine learning (random forest tree algorithm) with the most-described six imaging and three clinical features, a multivariable prediction model (the signature) was developed and validated for diagnosing PM. Signature performance was evaluated using area under a receiver operating characteristic curves (AUCs). RESULTS: Out of 3174 screened articles, 65 were included totalising 122 patients (HP: 60 pts, PM: 62 pts). Complete radiological data were available in 82 pts (Training: 62 pts, Validation: 20 pts). The signature reached an AUC = 0.91 (0.82, 1.00), P < 10-8 in the training set and AUC = 0.94 (0.80, 1.00), P = 0.001 in the validation set. The signature predicted PM in lesions either ≥ 2 cm in size or < 2 cm if associated with heterogeneous contrast enhancement and cavernous extension. CONCLUSION: An image-based signature was developed with machine learning and validated for differentiating PM from HP. This tool could be used by clinicians for enhanced decision-making in cancer patients undergoing ICB treatment with new-onset, concerning lesions of the pituitary gland.
引用
- Mekki A, Dercle L, Lichtenstein P, et al. Machine learning defined diagnostic criteria for differentiating pituitary metastasis from autoimmune hypophysitis in patients undergoing immune checkpoint blockade therapy. Eur J Cancer. 2019. PMID: 31415986. doi:10.1016/j.ejca.2019.06.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。